Clinical Trial Update: VITdAL@ICU - Correction of Vitamin D Deficiency in Critically Ill Patients [Phase 3]

View source ↗

Summary

Phase 3 trial VITdAL@ICU evaluated high-dose cholecalciferol to correct vitamin D deficiency in critically ill adults. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Vitamin Deficiency

Drugs mentioned

• Cholecalciferol (Vitamin D3) (cholecalciferol)

Snippet

Sponsor: Harald Dobnig, MD | Conditions: Critical Illness, Vitamin D Deficiency | Phase 3 | Status: COMPLETED